Related Experiment Video
Updated: Aug 11, 2025
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.0K
Multidrug Resistance: The Growing Menace in PICU
1Department of Pediatric Intensive Care Unit, SIMS Hospital, Chennai, Tamil Nadu, India.
Summary
Multidrug resistance is a significant and increasing threat in pediatric intensive care units (PICUs). Addressing this challenge is crucial for improving patient outcomes and combating antimicrobial resistance.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Pharmacology
Background:
- Multidrug resistance (MDR) poses a growing threat in Pediatric Intensive Care Units (PICUs).
- The emergence of MDR complicates the treatment of common infections in critically ill children.
- Antimicrobial stewardship programs are essential to combat the rise of MDR.
Discussion:
- The escalating rates of multidrug resistance in PICUs necessitate urgent attention.
- Effective strategies are required to preserve the efficacy of existing antibiotics.
- Interdisciplinary collaboration is key to managing MDR effectively.
Key Insights:
- MDR is a critical challenge in pediatric critical care.
- Prompt and appropriate antibiotic selection is vital.
- Continuous monitoring and research are essential.
Outlook:
- Future research should focus on novel antimicrobial agents and treatment strategies.
- Enhanced infection control measures are paramount.
- Global collaboration is needed to address the antimicrobial resistance crisis.
More Related Videos
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
4.8K
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
26.4K
Related Concept Videos
01:30Development of Antibiotic Resistance
65
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
65
01:28Pulmonary Tuberculosis V
224
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
224
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:28Pneumonia IV: Management
412
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
412
01:27Combined Effects of Drugs: Synergism
4.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.4K
01:21Factors Affecting Drug Response: Overview
2.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K